Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

HRS.15: Safety and efficacy of VGLB procedure similar to RF ablation

BOSTON—Preliminary results of a randomized trial found the HeartLight visually-guided laser balloon (VGLB) system was as safe and effective as irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation.

FDA issues another recall for HeartWare

The FDA issued a Class I recall on a component of the HeartWare Ventricular Assist System. This latest recall targets a splice repair kit that fails when exposed to excessive force.

Data shows the CardioMEMS HF System adds incremental benefit when combined with device therapy and is cost effective

St. Jude Medical, Inc., a global medical device company, today announced important new data presented during the Heart Rhythm Society's (HRS) 36th annual Scientific Session supporting improved outcomes and cost-effectiveness of the CardioMEMS™ HF System for the management of Class III heart failure patients.

At Heart Rhythm 2015, an international panel of experts provides concise diagnosis and treatment recommendations to improve quality of care for patients with specific cardiovascular syndromes

The Heart Rhythm Society (HRS) has released a first-of-its-kind expert consensus statement on three specific cardiovascular disorders that also involve the autonomic nervous system. The 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope was written by an international group of experts and presented today at Heart Rhythm 2015, the Heart Rhythm Society’s 36th Annual Scientific Sessions.

Thumbnail

HRS.15: Early Micra TPS analysis shows 100 percent success in implantation

BOSTON—All 140 patients analyzed and enrolled in a single-arm, multicenter trial had successful implants with the Micra Transcatheter Pacing System (TPS), a miniaturized leadless pacemaker that is not yet approved in the U.S. The mean implant time was 37 minutes.

HRS.15: Uninterrupted rivaroxaban rivals warfarin with ablations

Patients with atrial fibrillation who received an uninterrupted novel oral anticoagulant during catheter ablation fared on par with those treated with an uninterrupted vitamin K antagonist. In either case, bleeding rates in the clinical trial were low.

HRS.15: Cryoballoon technique as effective as radiofrequency ablation

BOSTON—A single-center randomized trial found that pulmonary vein isolation with the cryoballoon ablation technique was as effective as open irrigated radiofrequency in patients with paroxysmal atrial fibrillation.

Thumbnail

Hospital size and type affect mortality following OAR and EVAR

Factors in hospitals such as their size and type affect mortality after patients undergo open abdominal aortic aneurysm repair (OAR) or endovascular abdominal aortic aneurysm repair (EVAR), according to a database analysis.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.